Arindam Pramanik

Dr. Arindam Pramanik

School of Medicine, St James's University Hospital, University of Leeds, Leeds, UK
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
APArindam Pramanik
Arindam Pramanik
DLDipranjan Laha
Dipranjan Laha
DBDebalina Bhattacharya
Debalina Bhattacharya
PPPanchanan Pramanik
Panchanan Pramanik
PKParimal Karmakar
Parimal Karmakar

12 May 2015 in Luminescence
Verified
Journal Article
Closed access
PDF file
SCSoumen Chandra
Soumen Chandra
DLDipranjan Laha
Dipranjan Laha
APArindam Pramanik
Arindam Pramanik
ACAngshuman Ray Chowdhuri
Angshuman Ray Chowdhuri
PKParimal Karmakar
Parimal Karmakar
SSSumanta Kumar Sahu
Sumanta Kumar Sahu

18 September 2024 in Molecular Pharmaceutics
Verified
Journal Article
Open access
HKHarpreet Kaur
Harpreet Kaur
BGBishmita Gogoi
Bishmita Gogoi
ISIra Sharma
Ira Sharma
DDDeepak Kumar Das
Deepak Kumar Das
MAMohd Ashif Azad
Mohd Ashif Azad
APArindam Pramanik
Arindam Pramanik
Hydrogels, composed of hydrophilic polymer networks, have emerged as versatile materials in biomedical applications due to their high water content, biocompatibility, and tunable properties. They mimic natural tissue environments, enhancing cell viability and function. Hydrogels' tunable physical properties allow for tailored antibacterial biomaterial, wound dressings, cancer treatment, and tissue engineering scaffolds. Their ability to respond to physiological stimuli enables the controlled release of therapeutics, while their porous structure supports nutrient diffusion and waste removal, fostering tissue regeneration and repair. In wound healing, hydrogels provide a moist environment, promote cell migration, and deliver bioactive agents and antibiotics, enhancing the healing process. For cancer therapy, they offer localized drug delivery systems that target tumors, minimizing systemic toxicity and improving therapeutic efficacy. Ocular therapy benefits from hydrogels' capacity to form contact lenses and drug delivery systems that maintain prolonged contact with the eye surface, improving treatment outcomes for various eye diseases. In mucosal delivery, hydrogels facilitate the administration of therapeutics across mucosal barriers, ensuring sustained release and the improved bioavailability of drugs. Tissue regeneration sees hydrogels as scaffolds that mimic the extracellular matrix, supporting cell growth and differentiation for repairing damaged tissues. Similarly, in bone regeneration, hydrogels loaded with growth factors and stem cells promote osteogenesis and accelerate bone healing. This article highlights some of the recent advances in the use of hydrogels for various biomedical applications, driven by their ability to be engineered for specific therapeutic needs and their interactive properties with biological tissues.

1 January 2014 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
DLDipranjan Laha
Dipranjan Laha
APArindam Pramanik
Arindam Pramanik
JMJyotirindra Maity
Jyotirindra Maity
AMAnanda Mukherjee
Ananda Mukherjee
PPPanchanan Pramanik
Panchanan Pramanik
PKParimal Karmakar
Parimal Karmakar

1 November 2014 in Materials Research Bulletin
Verified
Journal Article
Closed access
DLDipranjan Laha
Dipranjan Laha
APArindam Pramanik
Arindam Pramanik
ALAparna Laskar
Aparna Laskar
MJMadhurya Jana
Madhurya Jana
PPPanchanan Pramanik
Panchanan Pramanik
PKParimal Karmakar
Parimal Karmakar

8 August 2022 in Molecular Pharmaceutics
Verified
Journal Article
Open access
APArindam Pramanik
Arindam Pramanik
ZXZexi Xu
Zexi Xu
NINicola Ingram
Nicola Ingram
PCPatricia Louise Coletta
Patricia Louise Coletta
PMPaul A Millner
Paul A Millner
THThomas Hughes
Thomas Hughes
Delivery of chemotherapy drugs specifically to cancer cells raises local drug doses in tumors and therefore kills more cancer cells while reducing side effects in other tissues, thereby improving oncological and quality of life outcomes. Cubosomes, liquid crystalline lipid nanoparticles, are potential vehicles for delivery of chemotherapy drugs, presenting the advantages of biocompatibility, stable encapsulation, and high drug loading of hydrophobic or hydrophilic drugs. However, active targeting of drug-loaded cubosomes to cancer cells, as opposed to passive accumulation, remains relatively underexplored. We formulated and characterized cubosomes loaded with potential cancer drug copper acetylacetonate and functionalized their surfaces using click chemistry coupling with hyaluronic acid (HA), the ligand for the cell surface receptor CD44. CD44 is overexpressed in many cancer types including breast and colorectal. HA-tagged, copper-acetylacetonate-loaded cubosomes have an average hydrodynamic diameter of 152 nm, with an internal nanostructure based on the space group Im3m. These cubosomes were efficiently taken up by two CD44-expressing cancer cell lines (MDA-MB-231 and HT29, representing breast and colon cancer) but not by two CD44-negative cell lines (MCF-7 breast cancer and HEK-293 kidney cells). HA-tagged cubosomes caused significantly more cell death than untargeted cubosomes in the CD44-positive cells, demonstrating the value of the targeting. CD44-negative cells were equally relatively resistant to both, demonstrating the specificity of the targeting. Cell death was characterized as apoptotic. Specific targeting and cell death were evident in both 2D culture and 3D spheroids. We conclude that HA-tagged, copper-acetylacetonate-loaded cubosomes show great potential as an effective therapeutic for selective targeting of CD44-expressing tumors.